We are live on ! Find out more
LMAT icon

LeMaitre Vascular

182 hedge funds and large institutions have $845M invested in LeMaitre Vascular in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 64 increasing their positions, 66 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.73% less ownership

Funds ownership: 87.27%86.54% (-0.73%)

3% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 66

4% less funds holding

Funds holding: 189182 (-7)

13% less capital invested

Capital invested by funds: $971M → $845M (-$126M)

22% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 23

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
182
Holders Change
-7
Holders Change %
-3.7%
% of All Funds
2.93%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
18
Increased
64
Reduced
66
Closed
23
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
HL
201
Harding Loevner
New Jersey
-$10K -192 Closed
FGAM
202
Financial Gravity Asset Management
Texas
-$292 -153 Closed
CFFP
203
Center for Financial Planning
Michigan
-$3K -63 Closed
GWS
204
Glassman Wealth Services
Virginia
-$1K -10 Closed

LMAT Hedge Fund Activity: Q4 2022 in Review

182 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q4 2022, worth a combined $845M — down 13% from $971M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of LMAT and 18 opened new positions — a net loss of 5 holders — while 66 trimmed existing stakes and 64 added.

The largest buyer was Copeland Capital Management, adding an estimated $2.52M. The largest seller was VOYA Investment Management, cutting an estimated $9.07M.

  • 182 institutional investors held LeMaitre Vascular (LMAT) as of Q4 2022, down from 189 in Q3 2022.
  • Funds reported $845M of LeMaitre Vascular stock for Q4 2022, down 13% quarter-over-quarter.
  • 18 funds opened new LeMaitre Vascular positions in Q4 2022 and 23 closed out, a net change of -5 holders.
  • The largest LeMaitre Vascular buyer in Q4 2022 was Copeland Capital Management, an estimated $2.52M added.
  • The largest LeMaitre Vascular seller in Q4 2022 was VOYA Investment Management, an estimated $9.07M sold.

Based on aggregated 13F filings for Q4 2022.